List of insiders holdings for Adamas Pharmaceuticals Inc:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| MDV IX LP Seventh MDV Partners L.L.C. Ninth MDV Partners L.L.C. FEIBER JONATHAN D SCHOENDORF NANCY J MDV ENF VII (A) L.P. MDV ENF VII (B) L.P. MDV VII Leaders' Fund L.P. MDV VII LP 10% Owner | 2018-02-14 13:03:37 | 4,698,796 0 | 4,698,796 | Form 13D |
| Went Gregory T Chief Executive Officer | 2020-02-14 16:01:23 | 1,447,441 0 | 1,447,441 | Form 13G |
| aeris Capital Equity Investments L.P. 10% Owner | 2016-02-12 09:07:30 | 837,128 0 | 837,128 | Form 13G |
| Rimac Anthony M Chief Financial Officer | 2014-04-09 18:34:58 | 260,000 0 | 260,000 | Form 3 |
| GREAT POINT PARTNERS LLC JAY JEFFREY R KROIN DAVID 10% Owner | 2017-10-10 16:14:12 | 256,340 0 | 256,340 | Form 13G |
| COFFEE MICHAEL DENIS Senior VP, Strategy & Planning | 2014-04-10 15:32:36 | 175,416 0 | 175,416 | Form 3 |
| Patni Rajiv Chief Medical Officer | 2019-04-10 16:26:26 | 109,141 0 | 109,141 | Form 4 |
| LIEBERBURG IVAN M Director | 2020-06-05 18:45:01 | 63,000 16,000 | 79,000 | Form 4 |
| Knapp Jeffrey H Chief Operating Officer | 2015-02-27 17:24:48 | 65,000 0 | 65,000 | Form 4 |
| Shin Grace General Counsel | 2014-12-03 19:04:24 | 65,000 0 | 65,000 | Form 4 |
| Rhodes Jennifer J CBO, GC & Compliance Officer | 2019-06-21 17:38:30 | 63,114 0 | 63,114 | Form 4 |
| KING RICHARD Chief Operating Officer | 2018-06-22 16:47:52 | 48,856 0 | 48,856 | Form 4 |
| MERRIWEATHER ALFRED G Chief Financial Officer | 2019-09-23 16:19:22 | 48,019 0 | 48,019 | Form 4 |
| McClure Natalie SVP, Product Development | 2016-04-20 17:49:11 | 25,006 0 | 25,006 | Form 4 |
| Dier Mardi Director | 2021-06-04 16:13:53 | 20,000 0 | 20,000 | Form 4 |
| Lewis Sara Grootwassink Director | 2015-05-18 17:25:28 | 18,000 0 | 18,000 | Form 4 |
| BOOTH RICHARD H Director | 2017-06-02 16:40:27 | 15,000 0 | 15,000 | Form 4 |
| DAWSON WILLIAM J Chief Financial Officer | 2017-03-22 17:02:41 | 14,284 0 | 14,284 | Form 4 |
| DAG Ventures Management III LLC DAG VENTURES III-QP LP DAG Ventures III L.P. DAG Ventures GP Fund III LLC Cadeddu John J. Goodrich R. Thomas 10% Owner | 2016-02-10 06:10:07 | 0 0 | 0 | Form 13G |
| MacPhee John A Director | 2021-11-24 16:07:50 | 0 0 | 0 | Form 4 |
| DEMSKI MARTHA J Director | 2021-11-24 16:08:14 | 0 0 | 0 | Form 4 |
| RICHO ANNA Director | 2021-11-24 16:08:47 | 0 0 | 0 | Form 4 |
| Papapetropoulos Spyridon Director | 2021-11-24 16:09:09 | 0 0 | 0 | Form 4 |
| Shreedhar Vijay Chief Commercial Officer | 2021-11-24 16:09:36 | 0 0 | 0 | Form 4 |
| Ericson William W. Director 10% Owner | 2021-11-24 16:09:56 | 0 0 | 0 | Form 4 |
| Prentiss Christopher B Chief Financial Officer | 2021-11-24 16:10:18 | 0 0 | 0 | Form 4 |
| McFarlane Neil F. Chief Executive Officer | 2021-11-24 16:10:40 | 0 0 | 0 | Form 4 |
| MAHONEY DAVID L Director | 2021-11-24 16:11:16 | 0 0 | 0 | Form 4 |
| BIGHAM MICHAEL Director | 2021-11-24 16:11:37 | 0 0 | 0 | Form 4 |